Larvol Delta - Acute-Myeloid-Leukemia-2021-Perspectives-on-Testing-Systemic-Therapies-and-Transplantation-Episode-4-SecondGeneration-FLT3-Inhibitors-for-Acute-Myeloid-Leukemia

Xospata (gilteritinib) - Astellas

Vanflyta (quizartinib) - Daiichi Sankyo

crenolanib besylate (ARO-002) - AROG

https://www.onclive.com/view/second-generation-flt3-inhibitors-for-acute-myeloid-leukemia

Jul 29, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next